CD Capital

Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.

Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.

Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.

Molbreeding is a biotechnology company specializing in molecular breeding technology for both animals and plants. It offers advanced genotyping solutions aimed at enhancing breeding processes. The firm emphasizes research and development in this field, utilizing proprietary technologies such as GenoPlexs and GenoBaits. These innovations provide customers with high capture efficiency, extensive coverage, and adaptable sample options, all while maintaining cost-effective custom services. Molbreeding's focus on molecular breeding positions it as a key player in the advancement of agricultural biotechnology.

Kanova is a biopharmaceutical company dedicated to the development of therapeutic antibodies and innovative combination therapies, specifically targeting immuno-oncology and autoimmune diseases. The company offers a biomedical technology service platform that supports pharmaceutical research and production in the biotechnology sector. By providing antibody-based drugs that enhance immune system functionality, along with technical consultation and drug quality inspection services, Kanova enables its clients to improve drug quality and efficiently advance the field of biomedicine.

Acchrom, also known as Huapu Instrument (Beijing) Technology Co., Ltd., is a prominent company specializing in chromatography, offering comprehensive solutions that include products, technical services, and support. The company's focus is on chromatographic separation products designed to effectively separate mixtures. Acchrom emphasizes a closed-loop system that integrates chromatography equipment, consumables, software, and customer services, thereby enabling clients to conduct chromatographic separation analysis efficiently. The company is dedicated to establishing itself as a well-known national brand in chromatography and has developed targeted marketing strategies and a professional sales team across key provinces to enhance its marketing network and presence in the industry.

Illumax is a company that specialises in the research and development of single-serve chemiluminescence, single-serve flow fluorescence, and laboratory automation technologies. It also offers the industry an open ecological platform for chemiluminescence and flow fluorescence.

Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.

Svision is a healthcare start-up that develops and produces high-end ophthalmic imaging equipment.

Better MedTech is a company dedicated to advancing urinary and pelvic floor health through the research, development, and production of specialized medical devices. It focuses on creating innovative solutions for conditions such as benign prostatic hyperplasia, urinary incontinence, urinary stones, and novel tumor therapies. By combining cutting-edge technology with comprehensive medical expertise, Better MedTech aims to deliver precise and effective products that enhance patient care and improve outcomes in these critical areas of health.

SprintRay is a manufacturer of 3D printing technology specifically designed for the dental industry. Founded in 2014, the company focuses on creating advanced, user-friendly products that empower dental professionals to enhance their services and respond swiftly to patient needs. By providing comprehensive additive manufacturing solutions, SprintRay aims to transform digital dentistry and expand the applications of desktop 3D printing in various sectors. The company's commitment to accessibility and reliability positions it as a forward-thinking player in the market, dedicated to improving the efficiency of dental practices and enhancing patient care.

Zhejiang Xunshi Technology Co., Ltd. specializes in the development and manufacturing of 3D printers, printing consumables, and 3D scanners. The company offers a range of desktop printers tailored for specific sectors, including the MoonRay D for dental applications, MoonRay J for jewelry, and MoonRay S for educational purposes. Its industrial printer lineup features the SLA laser rapid prototyping printer, the SolarRay DLP 3D printer, and ceramic 3D printers such as the CeraRay CR-I and CeraRay TC-I. Additionally, Xunshi produces 3D architectural printers designed for contour crafting and provides photosensitive resin and photocurable wax products for dentistry, jewelry, and ceramics. The company's desktop scanners serve various applications in dental medicine, education, research, and industry. Established in 2013, Xunshi Technology is headquartered in Shaoxing, China.

Neukio Biotherapeutics is a biopharmaceutical company dedicated to the development of immune cell therapies aimed at treating cancer. The company specializes in the research, development, and industrialization of allogenic immune cell drugs, particularly focusing on iPSC-CAR-NK cell products. By leveraging a combination of in-house innovation and strategic collaborations with leading partners, Neukio Biotherapeutics aims to provide effective therapeutic options for cancer patients globally. Their commitment to advancing oncology treatments positions them as a significant player in the field of immunotherapy.

Acchrom, also known as Huapu Instrument (Beijing) Technology Co., Ltd., is a prominent company specializing in chromatography, offering comprehensive solutions that include products, technical services, and support. The company's focus is on chromatographic separation products designed to effectively separate mixtures. Acchrom emphasizes a closed-loop system that integrates chromatography equipment, consumables, software, and customer services, thereby enabling clients to conduct chromatographic separation analysis efficiently. The company is dedicated to establishing itself as a well-known national brand in chromatography and has developed targeted marketing strategies and a professional sales team across key provinces to enhance its marketing network and presence in the industry.

Full-Life Technologies specializes in developing and commercializing radiopharmaceuticals for cancer therapy. It offers research and development, production, and distribution services within the radiotherapy sector, aiming to enhance patient outcomes through innovative nuclear medicine solutions.

HuidaGene Therapeutics Co., Ltd., established in 2018, is a Shanghai-based biotechnology company specializing in the research and development of gene therapies for single-gene disorders and neurodegenerative diseases. The company employs its proprietary CRISPR-based, AI-driven HG-PRECISE platform to create potentially curative treatments. HuidaGene's clinical pipeline includes therapies for RPE65-associated retinal disease (HG004), neovascular age-related macular degeneration (nAMD) (HG202), MECP2 duplication syndrome (HG204), and Duchenne muscular dystrophy (DMD) (HG302). Additionally, the company has preclinical programs focused on therapies for amyotrophic lateral sclerosis (ALS) and Alzheimer's disease.

Reliable Med is a medical device developer focused on creating and providing clinical mass spectrometry equipment for in vitro diagnostic (IVD) tests. The company addresses a significant need in the medical industry by offering high-end clinical mass spectrometry solutions and IVD detection kits. By enhancing diagnostic capabilities, Reliable Med aims to enable healthcare professionals to diagnose patients more efficiently and accurately.

Yingsheng Biotechnology Co., Ltd., established in 2009, specializes in the development of in vitro diagnostic reagents and medical equipment focused on maternal and child health, neonatal genetic diseases, metabolic disorders, and birth defects. The company offers a diverse product line that includes 45 innovative screening reagents for genetic metabolic diseases, deaf genetic testing kits, vitamins determination reagents, and an HLA-B27 detection kit. Yingsheng also provides advanced diagnostic technologies such as a mass spectrometer automatic intelligent processing platform and ultra-high performance liquid chromatography tandem mass spectrometry detection systems. Through its innovative products, Yingsheng aims to facilitate early detection of genetic conditions, promoting timely intervention and better health outcomes for patients.

Westlake Omics is a biotechnology company based in Hangzhou, Zhejiang, China, founded in 2020. The company specializes in mass spectrometry-based proteomics and other Omics technologies to meet critical clinical needs. Its primary focus is on advancing precision medicine and drug research and development through AI-driven high-throughput proteomic analysis of small clinical specimens. Westlake Omics aims to enhance clinical diagnostics, particularly in tumor detection, by providing reliable and innovative products that leverage technological advancements and multi-modal big data.

Wancheng Gene is a single-cell gene detection platform, which is mainly used to serve the scientific research, clinical and industrial markets with a self-developed high-throughput single-cell sequencing technology platform. The existing services of Wancheng Gene include sample preparation, database sequencing, analysis, and sample processing. They can be freely combined according to customer needs, and provide peripheral services such as sample preparation training and biometric analysis.

ForQaly is a medical device company specializing in the development of minimally invasive ventricular assist devices aimed at treating heart failure. The company focuses on creating therapeutic solutions that enhance circulation for patients, ensuring affordability and ease of use for healthcare providers. By prioritizing small trauma and large auxiliary flow in its designs, ForQaly's products are intended to offer effective and accessible care for individuals suffering from heart-related conditions, ultimately improving patient outcomes and quality of life.

Westlake Therapeutics is a biopharmaceutical company based in Hangzhou, China, founded in 2019. The company specializes in developing innovative cell therapies aimed at treating a range of human diseases, including cancer, rare disorders, and immunological and metabolic conditions. Central to its approach is the REDx platform, which enables the engineering of red blood cells and utilizes genetic modifications of hematopoietic stem and progenitor cells sourced from peripheral blood, bone marrow, or cord blood. This technology facilitates the creation of personalized treatment solutions, enhancing the potential for effective therapies tailored to individual patient needs.

Kanova is a biopharmaceutical company dedicated to the development of therapeutic antibodies and innovative combination therapies, specifically targeting immuno-oncology and autoimmune diseases. The company offers a biomedical technology service platform that supports pharmaceutical research and production in the biotechnology sector. By providing antibody-based drugs that enhance immune system functionality, along with technical consultation and drug quality inspection services, Kanova enables its clients to improve drug quality and efficiently advance the field of biomedicine.

Reliable Med is a medical device developer focused on creating and providing clinical mass spectrometry equipment for in vitro diagnostic (IVD) tests. The company addresses a significant need in the medical industry by offering high-end clinical mass spectrometry solutions and IVD detection kits. By enhancing diagnostic capabilities, Reliable Med aims to enable healthcare professionals to diagnose patients more efficiently and accurately.

Matridx is a company based in Hangzhou, China, specializing in the development, production, and sales of molecular diagnostic products aimed at diagnosing infectious diseases. The company utilizes advanced technologies such as CRISPR/Cas gene editing and high-throughput sequencing to create genetic testing kits that enhance the accuracy and efficiency of diagnostics. One of Matridx's notable offerings is the Potential Diagnostic Clue (PDC-Seq), which enables comprehensive sequencing of nucleic acids from samples taken from infected patients. By focusing on simplifying and accelerating the diagnostic process, Matridx aims to provide reliable genetic testing solutions that significantly improve the identification of infectious pathogens.

SeekGene is a company specializing in genetic data analysis solutions, particularly in the development and clinical application of single-cell sorting assays. With a team that possesses extensive research and clinical service experience, SeekGene aims to apply single-cell sequencing technology to real-world clinical research effectively. The company has developed a high-throughput single-cell transcriptome sequencing kit that is recognized for its superior performance, flexibility, simplicity, and cost-effectiveness. This innovative kit is designed to facilitate the clinical transformation of single-cell sequencing technology, enabling better understanding of immune responses at the single-cell level. By focusing on technologies related to T cell receptor and peptide-bound major histocompatibility complex pairing, SeekGene supports clinical and drug research as well as disease monitoring and treatment efforts.

MicroTech Medical, founded in January 2011 in Hangzhou Future Technical City, is a company focused on the research, development, and manufacturing of innovative and affordable medical devices for diabetes care. The firm specializes in creating both treatment and monitoring devices aimed at improving diabetes management, primarily serving the Chinese market while also reaching international customers. With significant backing from Eli Lilly and Company, MicroTech Medical is dedicated to enhancing the quality of life for individuals living with diabetes through advanced technology solutions.

Yingsheng Biotechnology Co., Ltd., established in 2009, specializes in the development of in vitro diagnostic reagents and medical equipment focused on maternal and child health, neonatal genetic diseases, metabolic disorders, and birth defects. The company offers a diverse product line that includes 45 innovative screening reagents for genetic metabolic diseases, deaf genetic testing kits, vitamins determination reagents, and an HLA-B27 detection kit. Yingsheng also provides advanced diagnostic technologies such as a mass spectrometer automatic intelligent processing platform and ultra-high performance liquid chromatography tandem mass spectrometry detection systems. Through its innovative products, Yingsheng aims to facilitate early detection of genetic conditions, promoting timely intervention and better health outcomes for patients.

Hugo Biotech is a developer of high-throughput microbial sequencing technology, specializing in the analysis of microbial genomes and associated big data. The company has sequenced nearly 20,000 clinical samples for over 300 leading hospitals in China. Its innovative approach allows for the rapid and precise detection of pathogenic microorganisms in clinical samples, bypassing traditional culturing processes and specific amplification methods. This technology enhances the efficiency of microbial identification in healthcare settings, contributing to improved patient outcomes through timely diagnosis and treatment.

Matridx is a company based in Hangzhou, China, specializing in the development, production, and sales of molecular diagnostic products aimed at diagnosing infectious diseases. The company utilizes advanced technologies such as CRISPR/Cas gene editing and high-throughput sequencing to create genetic testing kits that enhance the accuracy and efficiency of diagnostics. One of Matridx's notable offerings is the Potential Diagnostic Clue (PDC-Seq), which enables comprehensive sequencing of nucleic acids from samples taken from infected patients. By focusing on simplifying and accelerating the diagnostic process, Matridx aims to provide reliable genetic testing solutions that significantly improve the identification of infectious pathogens.

Shanghai Bioheart Biotechnology Co., Ltd., established in 2014 and located in Shanghai, China, specializes in the development of drug-eluting stents. The company is focused on creating innovative, high-value minimally invasive therapeutic products. Bioheart aims to enhance medical technology and provide superior healthcare solutions for medical professionals and patients alike, positioning itself as a significant player in the medical and healthcare industry.

HuidaGene Therapeutics Co., Ltd., established in 2018, is a Shanghai-based biotechnology company specializing in the research and development of gene therapies for single-gene disorders and neurodegenerative diseases. The company employs its proprietary CRISPR-based, AI-driven HG-PRECISE platform to create potentially curative treatments. HuidaGene's clinical pipeline includes therapies for RPE65-associated retinal disease (HG004), neovascular age-related macular degeneration (nAMD) (HG202), MECP2 duplication syndrome (HG204), and Duchenne muscular dystrophy (DMD) (HG302). Additionally, the company has preclinical programs focused on therapies for amyotrophic lateral sclerosis (ALS) and Alzheimer's disease.

Shanghai Bioheart Biotechnology Co., Ltd., established in 2014 and located in Shanghai, China, specializes in the development of drug-eluting stents. The company is focused on creating innovative, high-value minimally invasive therapeutic products. Bioheart aims to enhance medical technology and provide superior healthcare solutions for medical professionals and patients alike, positioning itself as a significant player in the medical and healthcare industry.

Xinzhi Medical is a Shanghai-based cardiovascular interventional therapy device developer.Xinzhi Medical is committed to promoting the technical innovation of cardiovascular interventional therapy and developing interventional non-implanted products in cardiovascular field continuously.

Pulse Medical Technology is a manufacturer specializing in the research, development, production, and sales of cardiovascular medical devices. The company's product portfolio includes wearable ECG monitoring equipment, extracorporeal shock wave therapy for heart treatment, auricle occluder systems, and heart parachute devices. These products are designed to assist doctors and surgeons in efficiently treating patients with chronic cardiovascular diseases and heart failure. Pulse Medical Technology operates as a manufacturer of second- and third-class medical devices within the cardiovascular industry, benefiting from government support and expert technical guidance.

Guangzhou Creative Biosciences, established in Guangzhou, China, specializes in the research, development, production, and sales of diagnostic kits for colorectal cancer screening. Their primary product is a non-invasive fecal DNA screening kit, which enables early detection of colorectal cancer by interpreting genetic abnormalities in feces. Additionally, the company offers diagnostic kits and equipment for lung cancer.

Accunome is a developer of molecular diagnostic technology that focuses on the research and development of diagnostic instruments and detection reagents. The company specializes in providing testing solutions for severe infectious diseases, enhancing diagnostic efficiency while aiming to reduce costs for its clients. Accunome's flagship platform, DXcellence12, has received state food and drug registration, as well as EU CE certification, further validating its commitment to high-quality diagnostic solutions. Additionally, the company offers a combined detection kit for influenza A/B and respiratory syncytial virus nucleic acid, which has also achieved EU CE certification. This positions Accunome as a key player in the molecular diagnostics field, aiming to improve healthcare outcomes through advanced technology.

Cellula is a medical and health company that provides IVD products. It is engaged in the field of reproductive health and provides integrated and cost-effective IVD products. They combine clinical needs to provide patients with accurate detection solutions and to provide inspectors with more convenient and technical products.

Urotronic Inc., established in 2014 and headquartered in Plymouth, Minnesota, specializes in developing and manufacturing medical devices for urological applications. The company's primary product is Optilume, a Drug Coated Balloon (DCB) catheter designed to treat urethral strictures in men by dilating the blocked area and delivering a drug that prevents scar tissue formation. This minimally invasive procedure reduces patient discomfort and recovery time compared to traditional surgical methods. Urotronic serves both urologists and patients, aiming to improve treatment outcomes for urinary tract conditions.

Quiknos creates the ability to combine mobile Internet with medical cold chain logistics and enters the market for medical services from the space of clinical medical examination, offering medical institutions services linked to platform software and medical cold chain transportation. They use complete medical cold chain logistics and information technology to assist grassroots doctors in improving their diagnosis and treatment levels. By enabling community-based medical institutions, quick and simple checks encourage the distribution of medical resources and make medical services accessible.

Ningbo Jenscare Scientific develops solutions around structural heart disease that include the treatment of the tricuspid valve, mitral valve, aortic valve, and heart failure. The company's contact information is its physical address.

CMAB BioPharm is a biopharmaceutical service firm based in Suzhou, China, specializing in process development and manufacturing services for biologic products. Established in 2017, the company offers customized development and manufacturing solutions for antibodies and biologics, catering to both domestic and international clients. CMAB BioPharm's services include process development, GMP manufacturing, and the production of aseptic drug products, adhering to stringent quality standards. The firm supports its customers through all stages of drug development, providing comprehensive solutions for preclinical and clinical phases, from initial DNA sequences to commercial production.

12 Sigma Technologies, founded in April 2015, is an innovative healthcare company that focuses on modern medical image diagnosis and medical data analysis. The company leverages advanced artificial intelligence technology to enhance medical imaging applications, recognizing the significant potential at the intersection of AI and healthcare. It has established partnerships with General Electric to collaboratively develop smart diagnostic products targeting tumors, cardiovascular diseases, and CT scans. Additionally, 12 Sigma has engaged with over 50 top-tier hospitals in China to facilitate applied medical diagnostics, technical research, and clinical trials, underscoring its commitment to advancing healthcare through cutting-edge technology.

Smartee Denti-Technology, established in 2004, specializes in developing and manufacturing invisible orthodontic systems. The company's flagship product, the Smartee aligner, combines 3D printing, CAD, and CAM technologies to accurately move teeth without the need for traditional braces. With over 23.6 million sets of aligners delivered worldwide, Smartee has a strong presence in China and serves global markets. The company employs over 1,700 people, including a medical team of over 380 professionals, and has obtained more than 500 patents. Smartee is recognized for its innovation and contributions to the Chinese invisible orthodontic industry, holding memberships in various industry associations and collaborations with renowned institutions like the University of North Carolina and China Aerospace.

Guangzhou Creative Biosciences, established in Guangzhou, China, specializes in the research, development, production, and sales of diagnostic kits for colorectal cancer screening. Their primary product is a non-invasive fecal DNA screening kit, which enables early detection of colorectal cancer by interpreting genetic abnormalities in feces. Additionally, the company offers diagnostic kits and equipment for lung cancer.

Microread is a commercialization company that focuses on sequencing technology platforms for genetic detection. They refined production processes and quality verification, and they developed a series of economical test reagents for forensic, clinical, agricultural, animal husbandry, and research fields.

Wallaby Medical, Inc., established in 2015, specializes in the manufacture and distribution of medical devices focused on treating stroke and neurovascular diseases. Headquartered in Laguna Hills, California, with operations in Shanghai, China, the company's primary product is the Wallaby Avenir Coil System, designed for treating intracranial aneurysms and other neurovascular abnormalities.

MicroTech Medical, founded in January 2011 in Hangzhou Future Technical City, is a company focused on the research, development, and manufacturing of innovative and affordable medical devices for diabetes care. The firm specializes in creating both treatment and monitoring devices aimed at improving diabetes management, primarily serving the Chinese market while also reaching international customers. With significant backing from Eli Lilly and Company, MicroTech Medical is dedicated to enhancing the quality of life for individuals living with diabetes through advanced technology solutions.

MicroTech Medical, founded in January 2011 in Hangzhou Future Technical City, is a company focused on the research, development, and manufacturing of innovative and affordable medical devices for diabetes care. The firm specializes in creating both treatment and monitoring devices aimed at improving diabetes management, primarily serving the Chinese market while also reaching international customers. With significant backing from Eli Lilly and Company, MicroTech Medical is dedicated to enhancing the quality of life for individuals living with diabetes through advanced technology solutions.

Singlera Genomics Inc. is a biotechnology company that specializes in genetic testing and molecular diagnostic technologies. Founded in 2014 and headquartered in La Jolla, California, with additional operations in Shanghai, China, Singlera develops a methylation detection platform designed for early cancer diagnosis and prevention. The company offers a range of services, including tumor diagnosis, personalized treatment, non-invasive prenatal diagnosis, and pre-implantation genetic screening. Additionally, Singlera is focused on advancing precision medicine, aiming to provide patients with early, accurate, and informative diagnostic solutions to improve healthcare outcomes.

SinoVision is a medical device manufacturing company based in China, established in 2012. It specializes in the development of computed tomography (CT) scanners, offering a range of products including 16-Slice, 32-Slice, and 64-Slice CT scanners. The company also provides advanced technologies such as the sROBOT robot CT navigation system and sAI intelligent imaging solutions. SinoVision holds intellectual property for CT detectors and designs X-ray tubes and high-voltage power supplies specifically for CT scanners. Additionally, it operates a cloud diagnosis platform that integrates CT image post-processing workstations with an online consultation platform, facilitating comprehensive imaging diagnoses for healthcare professionals and institutions.

Quiknos creates the ability to combine mobile Internet with medical cold chain logistics and enters the market for medical services from the space of clinical medical examination, offering medical institutions services linked to platform software and medical cold chain transportation. They use complete medical cold chain logistics and information technology to assist grassroots doctors in improving their diagnosis and treatment levels. By enabling community-based medical institutions, quick and simple checks encourage the distribution of medical resources and make medical services accessible.

Percutek Therapeutics is a manufacturer focused on the research, development, and production of minimally invasive interventional medical devices for cardiovascular applications. The company specializes in devices that facilitate non-invasive diagnosis and treatment of cardiovascular conditions, targeting areas such as the aorta, peripheral and coronary vasculature, as well as nerve intervention. Percutek Therapeutics is committed to delivering safe and effective solutions that enhance the treatment of vascular diseases, thereby improving patient outcomes in cardiovascular care.

Jiangsu Superbio Life Science Co., Ltd, founded in 2011 and based in Nanjing, China, specializes in gene sequencing and laboratory testing services. The company provides a range of services that include forensic and third-party medical testing, focusing on judicial and medical applications. Superbio utilizes advanced technology platforms, such as biochip technology, automated instruments, bioinformatics, and genetic engineering, to deliver its services. Its gene sequencing technology is particularly significant in forensic contexts, aiding in medical and legal disputes. Additionally, the company offers testing services related to food and drug safety, along with specialized services like paternity testing and forensic pathology identification, thereby catering to diverse client needs in the fields of health and law.

Righton is a Shanghai-based biotechnology company specializing in genetic engineering. It focuses on the research and development of in vitro diagnostic products, including molecular diagnostic reagent kits. The company is involved in various aspects of the biotechnology field, encompassing production, sales, and scientific research, as well as providing testing services. Righton aims to contribute to advancements in molecular diagnostics through its innovative products and services.

SinoVision is a medical device manufacturing company based in China, established in 2012. It specializes in the development of computed tomography (CT) scanners, offering a range of products including 16-Slice, 32-Slice, and 64-Slice CT scanners. The company also provides advanced technologies such as the sROBOT robot CT navigation system and sAI intelligent imaging solutions. SinoVision holds intellectual property for CT detectors and designs X-ray tubes and high-voltage power supplies specifically for CT scanners. Additionally, it operates a cloud diagnosis platform that integrates CT image post-processing workstations with an online consultation platform, facilitating comprehensive imaging diagnoses for healthcare professionals and institutions.

Med Lighter is a technology company based in Beijing, China, founded in 2014, that specializes in developing a learning and communication platform for medical professionals. The company's flagship application provides comprehensive medical imaging information across various body parts, utilizing modalities such as MRI, CT, X-ray, and ultrasound. In addition to imaging data, the application offers supplemental knowledge, including information on blood supply areas. Med Lighter also facilitates multi-center clinical trial collaborations, enabling the sharing of clinical cases and assisting healthcare providers with outpatient and inpatient medical record management and follow-up. This innovative platform aims to enhance the efficiency and effectiveness of medical professionals in their practice.

Biomarker Technologies, founded in 2009 and headquartered in Beijing, China, specializes in genomic services that integrate science, technology, and medical applications. The company offers a range of services including gene sequencing, scientific research, medical testing, and biological research, aimed at enhancing research capabilities for its clients. With a dedicated R&D team of over 500 highly skilled professionals, including technical staff, senior engineers, bioinformaticians, and experts in biotechnology, agriculture, and medicine, Biomarker Technologies is positioned as a key player in the genetic industry.

SinoVision is a medical device manufacturing company based in China, established in 2012. It specializes in the development of computed tomography (CT) scanners, offering a range of products including 16-Slice, 32-Slice, and 64-Slice CT scanners. The company also provides advanced technologies such as the sROBOT robot CT navigation system and sAI intelligent imaging solutions. SinoVision holds intellectual property for CT detectors and designs X-ray tubes and high-voltage power supplies specifically for CT scanners. Additionally, it operates a cloud diagnosis platform that integrates CT image post-processing workstations with an online consultation platform, facilitating comprehensive imaging diagnoses for healthcare professionals and institutions.